The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies

In order to improve the safety of COVID-19 vaccines, there is an urgent need to unravel the pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT), a severe complication of recombinant adenoviral vector vaccines used to prevent COVID-19, and likely due to anti-platelet factor 4 (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Vayne, Caroline, Palankar, Raghavendra, Billy, Sandra, Handtke, Stefan, Thiele, Thomas, Cordonnier, Charlotte, Pouplard, Claire, Greinacher, Andreas, Gruel, Yves, Rollin, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Platelet Biology & its Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521230/
https://www.ncbi.nlm.nih.gov/pubmed/35385923
http://dx.doi.org/10.3324/haematol.2021.280251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521230/
https://www.ncbi.nlm.nih.gov/pubmed/35385923
http://dx.doi.org/10.3324/haematol.2021.280251

Ejemplares similares